Our Expertise

Comprehensive Cleaning Validation Services

As a leading Contract Research Organization (CRO), we specialize in providing scientifically rigorous ADE/PDE, OEL, and OEB calculations that form the backbone of effective cleaning validation programs. Our services help pharmaceutical manufacturers prevent dangerous cross-contamination, achieve regulatory compliance, and maintain the highest safety standards for both patients and manufacturing personnel. With deep expertise in toxicological assessments and health-based exposure limits, we serve pharmaceutical companies, biotechnology firms, and fellow CROs worldwide. Following the proven methodologies of industry leaders like Indivirtus—who have successfully delivered over 13,000 PDE/ADE/OEL reports—we provide robust, compliant solutions for shared manufacturing facilities and equipment cleaning protocols.

Professional ADE PDE OEL OEB calculation services for pharmaceutical cleaning validation

Our Specialized Validation Services

Our Proven Cleaning Validation Process

Comprehensive Toxicological Assessment

We begin with thorough toxicological evaluations using the latest scientific data to accurately calculate ADE/PDE and OEL values for all active pharmaceutical ingredients (APIs) and intermediates in your manufacturing processes.

1

Strategic OEB Assignment

Our experts assign appropriate occupational exposure bands based on compound toxicity profiles, providing essential guidance for containment strategies and facility segregation decisions that protect worker safety.

2

Custom Cleaning Validation Protocol Development

We develop scientifically-backed, PDE-based cleaning protocols tailored to your facility, including precise MACO calculations and establishing appropriate rinse and swab limits for all shared manufacturing equipment.

3

Detailed Risk Assessment & Documentation

Our team prepares comprehensive Toxicological Risk Assessment (TRA) reports and cross-contamination evaluations that provide robust scientific support for regulatory compliance and successful audit outcomes.

4

Ongoing Regulatory Submission Support

We provide complete documentation packages for Product Quality Reviews (PQRs) and regulatory submissions, ensuring your facility maintains audit-ready status with all necessary scientific justifications.

5

Regulatory Compliance & International Standards

Global Regulatory Authorities

  • FDA (U.S. Food and Drug Administration) - American pharmaceutical standards
  • EMA (European Medicines Agency) - European Union compliance requirements
  • ICH (International Council for Harmonisation) - Global harmonized guidelines
  • CDSCO (Central Drugs Standard Control Organization) - Indian regulatory compliance
  • PIC/S, WHO, TGA - International pharmaceutical inspection standards

Industry Guidelines & Certifications

  • EMA Health-Based Exposure Limit (HBEL) Guidelines
  • PIC/S Good Manufacturing Practice Annex 15 Requirements
  • ISPE Risk-MaPP (Risk-based Manufacture of Pharmaceutical Products)
  • ICH Q3D (Elemental Impurities) and ICH Q9 (Quality Risk Management)
  • NIOSH/ACGIH Occupational Exposure Standards

Target Applications & Industries

  • Large-Scale Pharmaceutical Manufacturing Operations
  • Biotechnology and Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Active Pharmaceutical Ingredient (API) and Intermediates Production
  • Contract Development and Manufacturing Organizations (CDMOs)

Why Choose Our Expert Cleaning Validation Services?

Our Contract Research Organization delivers industry-leading ADE/PDE, OEL, and cleaning validation services that ensure safe, compliant pharmaceutical manufacturing operations. With our scientifically rigorous toxicological approach and strict alignment with EMA guidelines, PIC/S standards, and ISPE best practices, we help you minimize cross-contamination risks while maintaining full audit readiness. Choose our proven expertise for precise, health-based solutions that protect both patients and workers while meeting the most stringent global regulatory standards.

Let’s build something sustainable together →

Frequently Asked Questions

Frequently Asked Questions

What is ADE and why is it crucial for pharmaceutical cleaning validation? +

ADE (Acceptable Daily Exposure) represents the maximum amount of a pharmaceutical substance that patients can safely be exposed to on a daily basis. It's essential for determining cross-contamination limits in multiproduct facilities, ensuring that residual APIs from previous batches don't pose health risks to patients receiving different medications.

How do you calculate PDE for active pharmaceutical ingredients? +

PDE (Permitted Daily Exposure) calculation involves comprehensive analysis of toxicological data including NOAEL (No Observed Adverse Effect Level), LOAEL (Lowest Observed Adverse Effect Level), and appropriate safety factors. Our expert toxicologists use EMA-approved methodologies to establish cleaning limits that ensure residual API levels remain safe for patients.

Why are OEL calculations important for pharmaceutical manufacturing safety? +

OEL (Occupational Exposure Limit) calculations are critical for protecting manufacturing workers who handle potent pharmaceutical compounds. They define the maximum allowable airborne concentration of APIs that workers can be exposed to without adverse health effects, ensuring workplace safety compliance.

What is OEB and how does it benefit pharmaceutical manufacturers? +

OEB (Occupational Exposure Banding) categorizes pharmaceutical compounds based on their toxicity profiles when specific OEL data isn't available. This system helps manufacturers determine appropriate containment measures, personal protective equipment requirements, and facility design specifications for safe handling.

Do all pharmaceutical products require ADE/PDE/OEL calculations? +

ADE/PDE/OEL calculations are essential for multiproduct facilities and when handling highly potent APIs. These calculations are required by regulatory authorities including EMA, ICH, and WHO for cleaning validation and risk mitigation, ensuring patient safety and regulatory compliance.

Can your ADE/PDE reports withstand regulatory audits and inspections? +

Absolutely. Our comprehensive reports are fully audit-ready and compliant with EMA guidelines, ICH Q3D standards, and ISPE best practices. We provide detailed scientific justifications and support during regulatory inspections, ensuring your facility meets all compliance requirements.

What does your ADE/PDE calculation process involve for cleaning validation? +

Our process includes comprehensive toxicological assessment of APIs and intermediates, utilizing NOAEL, LOAEL, and adjustment factors according to EMA guidelines. We establish health-based exposure limits that form the scientific foundation for effective cleaning validation protocols.

How do you determine accurate Occupational Exposure Limits (OEL)? +

We calculate OELs using extensive toxicological data analysis, airborne exposure risk modeling, and route-specific limit assessments (including inhalation and dermal exposure). Our calculations include comparisons with established NIOSH, ACGIH, and REACH database standards for validation.

What role does OEB play in pharmaceutical manufacturing operations? +

OEB assigns pharmaceutical compounds to specific exposure bands (typically 1–5 or A–F categories) based on their toxicity and pharmacological activity profiles. This banding guides critical decisions about containment system design, facility segregation requirements, and worker protection measures.

How do PDE values support effective cleaning validation protocols? +

PDE values provide the scientific basis for calculating Maximum Allowable Carryover (MACO), establishing appropriate rinse and swab sampling limits, and developing health-based cleaning validation protocols that comply with EMA, PIC/S, and Annex 15 regulatory requirements.

Which organizations benefit most from your cleaning validation services? +

Our services benefit pharmaceutical manufacturers, biotechnology companies, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs) by ensuring safe operation of shared equipment and facilities while reducing cross-contamination risks and maintaining regulatory compliance.

What components are included in your Toxicological Risk Assessment (TRA) reports? +

Our comprehensive TRA reports include detailed compound-specific toxicology monographs, scientific cleaning limit justifications, complete documentation for cleaning validation protocols, Product Quality Review (PQR) support materials, and all necessary documentation for regulatory submissions.